By Apex Financial Consultants : Kimberly - Clark ( KMB ) is considered to be a boring stock by many analysts. However, the company's restructuring plans, higher than industry return
and 3M Company MMM: TE Connectivity, 3M and AmerisourceBergen were all up significantly in the period. Monsanto, Kimberly - Clark , Automatic Data Processing Inc., Ingersoll Rand and Omnicom were among those sold over the past year. Most of
SCA develops an economic moat derived from strong consumer brands and begins to trade more in line with the likes of Kimberly - Clark and Procter & Gamble, which have a portfolio of proven brands. While SCA does have some solid brands in Tork away
NEW YORK, Nov 15 (Reuters) - Kimberly Clark shares dropped slightly Friday morning after the company said during a press call that the potential spin off of its healthcare division still needs board...
Kimberly - Clark Corporation ( KMB ) declares $0.81/share quarterly dividend , in line with previous. Forward yield 2.96% Payable Jan 3; for shareholders of record Dec. 6; ex-div Dec. 4. Post your comment!
Thursday November 14. Troubles about Bubbles? Kimberly - Clark ( KMB ), General Motors ( GM ), Clean Energy Fuels ..... bubble by discussing fundamentals of companies. Kimberly - Clark ( KMB ) rose on the news of a spin-off and stocks seem
Breakfast Editors submit: Top Stories Kimberly - Clark to spin off healthcare ops. Kimberly - Clark ( KMB ) intends to spin its healthcare business ..... makes sense," CEO Thomas Falk said. Kimberly - Clark hopes to complete the spin-off by the
looked to shed some fat lately, Kimberly - Clark announced on Thursday its intent ..... health-care business will enable Kimberly to hone its resources (both financial ..... of our narrow moat rating-- Kimberly - Clark should withstand the challenges
(Reuters) - Kimberly - Clark Corp , the maker of Kleenex tissues, said its board authorized a potential spin-off of its health care business, sending its shares up 6 percent in extended trading.
Nov 14 (Reuters) - Kimberly - Clark Corp, the maker of Kleenex tissues, said its board authorized a potential spin-off of its health care business, sending its shares up 6 percent in extended trading.